Heparanase 1 (HPSE) Human shRNA Plasmid Kit (Locus ID 10855)
CAT#: TR307138
HPSE - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
货期*
现货
规格
Cited in 4 publications. |
Product images
经常一起买 (2)
Specifications
Product Data | |
Product Name | Heparanase 1 (HPSE) Human shRNA Plasmid Kit (Locus ID 10855) |
Locus ID | 10855 |
UniProt ID | Q9Y251 |
Synonyms | HPA; HPA1; HPR1; HPSE1; HSE1 |
Vector | pRS |
Format | Retroviral plasmids |
Kit Components | HPSE - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector(Gene ID = 10855). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pRS Vector, TR30012, included for free. |
RefSeq | NM_001098540, NM_001166498, NM_001199830, NM_006665, NM_006665.1, NM_006665.2, NM_006665.3, NM_006665.4, NM_006665.5, NM_001098540.1, NM_001098540.2, NM_001166498.1, NM_001166498.2, NM_001199830.1, BC051321, BC051321.1, BC029464, NM_001098540.3 |
Summary | Heparan sulfate proteoglycans are major components of the basement membrane and extracellular matrix. The protein encoded by this gene is an enzyme that cleaves heparan sulfate proteoglycans to permit cell movement through remodeling of the extracellular matrix. In addition, this cleavage can release bioactive molecules from the extracellular matrix. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (4)
The use of this RNAi has been cited in the following citations: |
---|
Heparanase: A Potential New Factor Involved in the Renal Epithelial Mesenchymal Transition (EMT) Induced by Ischemia/Reperfusion (I/R) Injury
,Masola, V;Zaza, G;Gambaro, G;Onisto, M;Bellin, G;Vischini, G;Khamaysi, I;Hassan, A;Hamoud, S;Nativ, O;N Heyman, S;Lupo, A;Vlodavsky, I;Abassi, Z;,
PLoS ONE
,PubMed ID 27467172
[HPSE]
|
Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase
,Masola, V;Zaza, G;Granata, S;Gambaro, G;Onisto, M;Lupo, A;,
J Transl Med 292
,PubMed ID 24256696
[HPSE]
|
Heparanase and Syndecan-1 Interplay Orchestrates Fibroblast Growth Factor-2-induced Epithelial-Mesenchymal Transition in Renal Tubular Cells
,Valentina Masola, Giovanni Gambaro, Elena Tibaldi, Anna Maria Brunati, Alessandra Gastaldello, Angela D'Angelo, Maurizio Onisto, and Antonio Lupo,
J. Biol. Chem., Jan 2012; 287: 1478 - 1488.
[HPSE]
|
Heparanase Alters Arterial Structure, Mechanics, and Repair Following Endovascular Stenting in Mice
,Baker, Aaron B.; Groothuis, Adam; Jonas, Michael; Ettenson, David S.; Shazly, Tarek; Zcharia, Eyal; Vlodavsky, Israel; Seifert, Philip; Edelman, Elazer R,
Circulation Research:Volume 104(3)13 February 2009pp 380-387
[HPSE]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...